Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics
QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics
QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics
Submitted by
admin
on July 9, 2011 - 11:00am
Source:
Yahoo/PR NewsWire
News Tags:
Ipsogen
Qiagen
M&A
Headline:
QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics
Do Not Allow Advertisers to Use My Personal information
